These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26760117)

  • 1. PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells.
    Ishii J; Yazawa T; Chiba T; Shishido-Hara Y; Arimasu Y; Sato H; Kamma H
    Endocrinology; 2016 Mar; 157(3):1289-98. PubMed ID: 26760117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.
    Saglietti C; La Rosa S; Sykiotis GP; Letovanec I; Bulliard JL; Piana S; Mermod M; Petrova T; Uccella S; Sessa F; Bongiovanni M
    Endocr Pathol; 2019 Jun; 30(2):138-145. PubMed ID: 31001799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.
    Rudzińska M; Mikula M; Arczewska KD; Gajda E; Sabalińska S; Stępień T; Ostrowski J; Czarnocka B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Signature of Prospero Homeobox 1 (PROX1) in Follicular Thyroid Carcinoma Cells.
    Rudzińska M; Grzanka M; Stachurska A; Mikula M; Paczkowska K; Stępień T; Paziewska A; Ostrowski J; Czarnocka B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy.
    Rudzińska M; Czarnocka B
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
    Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
    Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas.
    Ramone T; Romei C; Ciampi R; Tacito A; Piaggi P; Torregrossa L; Ugolini C; Elisei R
    Endocrine; 2019 Sep; 65(3):623-629. PubMed ID: 31278686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.
    Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
    J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer.
    Gurgul E; Kasprzak A; Blaszczyk A; Biczysko M; Surdyk-Zasada J; Seraszek-Jaros A; Ruchala M
    Folia Histochem Cytobiol; 2015; 53(1):19-25. PubMed ID: 25765090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MicroRNAs in Thyroid Carcinoma.
    Zhu G; Xie L; Miller D
    Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine secretory granule production is caused by a lack of REST and intragranular secretory content and accelerated by PROX1.
    Ishii J; Sato-Yazawa H; Kashiwagi K; Nakadate K; Iwamoto M; Kohno K; Miyata-Hiramatsu C; Masawa M; Onozaki M; Noda S; Miyazawa T; Takagi M; Yazawa T
    J Mol Histol; 2022 Apr; 53(2):437-448. PubMed ID: 35094211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid.
    Schmid KW; Kirchmair R; Ladurner D; Fischer-Colbrie R; Böcker W
    Histopathology; 1992 Sep; 21(3):225-32. PubMed ID: 1356907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells.
    Kashiwagi K; Ishii J; Sakaeda M; Arimasu Y; Shimoyamada H; Sato H; Miyata C; Kamma H; Aoki I; Yazawa T
    Pathol Int; 2012 Apr; 62(4):232-45. PubMed ID: 22449227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric hamartoma and thyroid gland carcinoma with follicular and neuroendocrine differentiation in Cowden syndrome].
    Marth T; Schmitt-Gräff A; Zimmer T; Riecken EO; Wiedenmann B
    Z Gastroenterol; 1996 Jan; 34(1):30-5. PubMed ID: 8776173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
    Choi D; Ramu S; Park E; Jung E; Yang S; Jung W; Choi I; Lee S; Kim KE; Seong YJ; Hong M; Daghlian G; Kim D; Shin E; Seo JI; Khatchadourian V; Zou M; Li W; De Filippo R; Kokorowski P; Chang A; Kim S; Bertoni A; Furlanetto TW; Shin S; Li M; Chen Y; Wong A; Koh C; Geliebter J; Hong YK
    Cancer Res; 2016 Feb; 76(3):582-93. PubMed ID: 26609053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine.
    Kumarasamy VM; Shin YJ; White J; Sun D
    BMC Cancer; 2015 Aug; 15():599. PubMed ID: 26307103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.